The main effect of IL-10 is macrophage inhibition, together with TNF-α and IL-1 production; Myhr et al. (2003) proposed that IL-10 and its promoter polymorphisms can develop GBS by increasing the ganglioside antibody generation [143]. Here, IL10 is linked to Guillain-Barre syndrome.